Zealand, Roche release phase 2 topline data for amylin analogue petrelintide
Related news
-
Eric L. Oliver, Cross Timbers director, buys $87,575 in units
-
Optimum communications director Neil Subin acquires $2.45m in stock
-
Ul solutions CEO Scanlon sells $876k of company stock
-
Sequoia-backed Nuvacore seeks $2.5bn valuation in funding round - Reuters
-
Datadog CTO Alexis Le-Quoc sells $14.75m in shares
-
Trump says Russia to supply diesel to US and global markets
-
Mediaalpha CEO Steven Yi sells $263k in company stock
-
InnSuites Hospitality Trust CEO Wirth reports $2.17 billion share disposition